This inventor holds 1 USPTO granted patent. Top assignee: Probiogen Ab. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Katrin John: Innovator in Porcine Cell Line Technology
Introduction
Katrin John is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of cell lines for virus production. Her innovative work has the potential to impact various applications in virology and vaccine development.
Latest Patents
Katrin John holds a patent for a continuous porcine cell line that is capable of proliferating in medium free of animal-derived components. This invention relates to a method for producing a virus using the cell line, as well as a virus obtainable by this method. Additionally, her patent includes a method for accumulating a virus from an environmental sample using the same cell line, showcasing her innovative approach to virology.
Career Highlights
Katrin John is associated with Probiogen AB, a company that specializes in biopharmaceutical development. Her work at Probiogen has allowed her to focus on advancing technologies that facilitate virus production and research. With her expertise, she has contributed to the growth and success of the company in the biotechnology sector.
Collaborations
Katrin has collaborated with notable colleagues such as Volker Sandig and Deborah Horn. These partnerships have enabled her to enhance her research and expand the impact of her inventions in the scientific community.
Conclusion
Katrin John's innovative work in developing a porcine cell line for virus production exemplifies her commitment to advancing biotechnology. Her contributions are paving the way for new methods in virology and have the potential to lead to significant advancements in the field.